PubRank
Search
About
T Lorf
Author PubWeight™ 36.35
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
Transplantation
2001
1.51
2
Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts.
J Exp Med
1997
1.44
3
Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column.
Transplantation
1998
1.23
4
Update of current immunosuppressive drugs used in clinical organ transplantation.
Transpl Int
1998
1.07
5
Characterization of a monoclonal anti-porcine CD3 antibody.
Xenotransplantation
1999
1.01
6
Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine. Effect of administration of exogenous IL-2.
J Immunol
1994
0.99
7
Presence of melatonin in the human hepatobiliary-gastrointestinal tract.
Life Sci
2001
0.98
8
Situs inversus of donor or recipient in liver transplantation.
Transpl Int
1998
0.94
9
Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.
Int J Colorectal Dis
2008
0.93
10
Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses.
Transplantation
1995
0.93
11
Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts.
Transplantation
1999
0.92
12
Induction of tolerance to renal allografts across single-haplotype MHC disparities in miniature swine.
Transplantation
1995
0.90
13
Porcine-to-primate orthotopic liver transplantation.
Transplant Proc
1994
0.89
14
Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity.
Transplantation
1997
0.89
15
Mechanism of tolerance to class I-mismatched renal allografts in miniature swine: regulation of interleukin-2 receptor alpha-chain expression on CD8 peripheral blood lymphocytes of tolerant animals.
Transplantation
1998
0.88
16
Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine-specific growth factors.
Transplantation
1999
0.88
17
Pig to monkey bone marrow and kidney xenotransplantation.
Surgery
1997
0.88
18
Is a fatty liver dangerous for transplantation?
Transplant Proc
1999
0.87
19
Selective increase in CD4-positive graft-infiltrating mononuclear cells among the infiltrates in class I disparate kidney grafts undergoing rejection.
Transplantation
1997
0.87
20
Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine.
Transplantation
1997
0.85
21
Hepatic blood supply: comparison of optimized dual phase contrast-enhanced three-dimensional MR angiography and digital subtraction angiography.
Radiology
1999
0.85
22
Pitfalls in monitoring tacrolimus (FK 506).
Ther Drug Monit
1997
0.85
23
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Transplant Proc
1996
0.84
24
Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand.
Transplantation
2001
0.83
25
The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
Z Gastroenterol
2003
0.83
26
Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: role of liver transplantation.
World J Surg
2001
0.82
27
Therapeutic drug monitoring of tacrolimus early after liver transplantation.
Transplant Proc
2002
0.82
28
Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
Nephrol Dial Transplant
1998
0.82
29
[Malignant fibrous histiocytoma of the liver].
Z Gastroenterol
2000
0.81
30
Long-term acceptance of primarily vascularized renal allografts in miniature swine. Systemic tolerance versus graft adaptation.
Transplantation
1996
0.81
31
Von Willebrand gene expression in damaged human liver.
Hepatogastroenterology
2004
0.81
32
Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.
Int J Colorectal Dis
2012
0.78
33
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
Transplant Proc
1998
0.78
34
Undifferentiated small cell hepatoblastoma with a chromosomal translocation t(22;22)(q11;q13).
Histopathology
2002
0.78
35
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
Anticancer Res
1999
0.77
36
How to handle mycophenolate mofetil in combination with tacrolimus?
Transplant Proc
1998
0.77
37
Surgical treatment of cholangiocellular carcinoma.
Swiss Surg
1999
0.77
38
The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients.
Eur J Clin Pharmacol
2000
0.76
39
Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.
Am J Transplant
2012
0.76
40
Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival.
Int J Colorectal Dis
2013
0.76
41
Expression of E-selectin and its transcripts during intestinal ischemia-reperfusion injury in pigs.
Transplant Proc
2004
0.75
42
Pantoprazole and cyclosporine or tacrolimus.
Aliment Pharmacol Ther
2001
0.75
43
Graft rupture after living donor liver transplantation.
Transplant Proc
2002
0.75
44
Treatment of transplant ureteral stenosis with Acucise endoureterotomy.
Transpl Int
1998
0.75
45
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
Transplant Proc
1998
0.75
46
[Results of treatment of pyogenic liver abscesses].
Zentralbl Chir
1987
0.75
47
[Surgical treatment of malignant tumor of the hepatic duct junction].
Zentralbl Chir
1990
0.75
48
Development of a porcine small bowel ex vivo perfusion model.
Transplant Proc
1998
0.75
49
[Surgical therapy of benign liver tumors].
Internist (Berl)
1997
0.75
50
Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
Transplant Proc
1998
0.75
51
Differential gene expression during intestinal ischemia-reperfusion injury.
Transplant Proc
2002
0.75
52
[Technical aspects of segment I resection of the liver].
Langenbecks Arch Chir Suppl Kongressbd
1996
0.75
53
[Undifferentiated small-cell hepatoblastoma].
Pathologe
2000
0.75
54
[Fractures of the extremities with open soft tissue injury. Complications and treatment concept].
Zentralbl Chir
1986
0.75
55
Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
Transplant Proc
2000
0.75
56
Liver transplantation for primary liver cancer.
Transplant Proc
1996
0.75
57
Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism.
Transplant Proc
1994
0.75
58
Inhibition of in vitro immunoglobulin synthesis by Brucella melitensis.
Tokai J Exp Clin Med
1986
0.75
59
Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients.
Transplant Proc
2001
0.75
60
[Stage-dependent approach to stomach cancer].
Zentralbl Chir
1989
0.75
61
Humoral response of miniature swine tolerant to class I mismatched renal allografts.
Transplant Proc
1995
0.75
62
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation?
Transplant Proc
1998
0.75
63
Lectin staining for urine cytologic monitoring after kidney transplantation.
Transplant Proc
2002
0.75
64
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
Transplant Proc
2000
0.75
65
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk".
Transplant Proc
2000
0.75